1. A New Liver Expression Quantitative Trait Locus Map From 1, 183 Individuals Provides Evidence for Novel Expression Quantitative Trait Loci of Drug Response, Metabolic, and Sex‐Biased Phenotypes. Issue 6 (30th January 2020) Authors: Etheridge, Amy S.; Gallins, Paul J.; Jima, Dereje; Broadaway, K. Alaine; Ratain, Mark J.; Schuetz, Erin; Schadt, Eric; Schroder, Adrian; Molony, Cliona; Zhou, Yihui; Mohlke, Karen L.; Wright, Fred A.; Innocenti, Federico Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 6(2020) Page Start: 1383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients. Issue 12 (December 2015) Authors: Chen, Sylvia; Villeneuve, Lyne; Jonker, Derek; Couture, Félix; Laverdière, Isabelle; Cecchin, Erica; Innocenti, Federico; Toffoli, Giuseppe; Lévesque, Eric; Guillemette, Chantal Journal: Pharmaocogenetics and genomics Issue: Volume 25:Issue 12(2015:Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance). Issue 3 (6th September 2022) Authors: Raghav, Kanwal; Ou, Fang-Shu; Venook, Alan P.; Innocenti, Federico; Sun, Ryan; Lenz, Heinz-Josef; Kopetz, Scott Journal: Journal of clinical oncology Issue: Volume 41:Issue 3(2023) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis. Issue 4 (May 2022) Authors: McCleary, Nadine J.; Zhang, Sui; Ma, Chao; Ou, Fang-Shu; Bainter, Tiffany M.; Venook, Alan P.; Niedzwiecki, Donna; Lenz, Heinz-Josef; Innocenti, Federico; O'Neil, Bert H.; Polite, Blase N.; Hochster, Howard S.; Atkins, James N.; Goldberg, Richard M.; Ng, Kimmie; Mayer, Robert J.; Blanke, Charles ... Journal: Journal of geriatric oncology Issue: Volume 13:Issue 4(2022) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. All You Need to Know About UGT1A1 Genetic Testing for Patients Treated With Irinotecan: A Practitioner-Friendly Guide. Issue 4 (3rd April 2022) Authors: Karas, Spinel; Innocenti, Federico Journal: JCO oncology practice Issue: Volume 18:Issue 4(2022) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance). Issue 6 (August 2019) Authors: Innocenti, Federico; Jiang, Chen; Sibley, Alexander B.; Denning, Stefanie; Etheridge, Amy S.; Watson, Dorothy; Niedzwiecki, Donna; Hatch, Ace J.; Hurwitz, Herbert I.; Nixon, Andrew B.; Furukawa, Yoichi; Kubo, Michiaki; Crona, Daniel J.; Kindler, Hedy L.; McLeod, Howard L.; Ratain, Mark J.; Owzar,... Journal: Pharmaocogenetics and genomics Issue: Volume 29:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Architecture of pharmacogenomic associations: structures with functional foundations or castles made of sand?. (January 2013) Authors: Glubb, Dylan M; Innocenti, Federico Journal: Pharmacogenomics Issue: Volume 14:Number 1(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Architecture of pharmacogenomic associations: structures with functional foundations or castles made of sand?. (January 2013) Authors: Glubb, Dylan M; Innocenti, Federico Journal: Pharmacogenomics Issue: Volume 14:Number 1(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). (27th July 2016) Authors: Hatch, Ace J.; Sibley, Alexander B.; Starr, Mark D.; Brady, J. Chris; Jiang, Chen; Jia, Jingquan; Bowers, Daniel L.; Pang, Herbert; Owzar, Kouros; Niedzwiecki, Donna; Innocenti, Federico; Venook, Alan P.; Hurwitz, Herbert I.; Nixon, Andrew B. Journal: Cancer medicine Issue: Volume 5:Number 9(2016:Sep.) Page Start: 2249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405. Issue 3 (31st March 2020) Authors: Guercio, Brendan J; Zhang, Sui; Venook, Alan P; Ou, Fang-Shu; Niedzwiecki, Donna; Lenz, Heinz-Josef; Innocenti, Federico; Mullen, Brian C; O'Neil, Bert H; Shaw, James E; Polite, Blase N; Hochster, Howard S; Atkins, James N; Goldberg, Richard M; Brown, Justin C; O'Reilly, Eileen M; Mayer, Robert J... Journal: JNCI cancer spectrum Issue: Volume 4:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗